↓ Skip to main content

The Role of Cost-Effectiveness Analysis in the Era of Pharmacogenomics

Overview of attention for article published in PharmacoEconomics, September 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (76th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

policy
2 policy sources

Citations

dimensions_citation
98 Dimensions

Readers on

mendeley
87 Mendeley
Title
The Role of Cost-Effectiveness Analysis in the Era of Pharmacogenomics
Published in
PharmacoEconomics, September 2012
DOI 10.2165/00019053-200422080-00001
Pubmed ID
Authors

Christopher R. Flowers, David Veenstra

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 87 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 3 3%
United Kingdom 1 1%
Canada 1 1%
Brazil 1 1%
Unknown 81 93%

Demographic breakdown

Readers by professional status Count As %
Researcher 23 26%
Student > Master 16 18%
Student > Ph. D. Student 10 11%
Student > Doctoral Student 8 9%
Student > Bachelor 6 7%
Other 17 20%
Unknown 7 8%
Readers by discipline Count As %
Medicine and Dentistry 23 26%
Pharmacology, Toxicology and Pharmaceutical Science 18 21%
Agricultural and Biological Sciences 10 11%
Economics, Econometrics and Finance 8 9%
Biochemistry, Genetics and Molecular Biology 5 6%
Other 13 15%
Unknown 10 11%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 January 2013.
All research outputs
#5,446,629
of 25,373,627 outputs
Outputs from PharmacoEconomics
#570
of 1,992 outputs
Outputs of similar age
#39,166
of 189,596 outputs
Outputs of similar age from PharmacoEconomics
#106
of 549 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,992 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.6. This one has gotten more attention than average, scoring higher than 64% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 189,596 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 76% of its contemporaries.
We're also able to compare this research output to 549 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.